Murthy et al. (2024) demonstrated that acetate derived from cancer-associated fibroblasts can drive the progression of pancreatic cancer by modulating polyamine metabolism through the ACSS2-SP1-SAT1 axis. This evidence concerns the gene SP1 and familial pancreatic carcinoma.